These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neuropeptides in Alzheimer's disease: from pathophysiological mechanisms to therapeutic opportunities. Van Dam D; Van Dijck A; Janssen L; De Deyn PP Curr Alzheimer Res; 2013 Jun; 10(5):449-68. PubMed ID: 23627705 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptides in neurological disease. Beal MF; Martin JB Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536 [TBL] [Abstract][Full Text] [Related]
10. Neuropeptides in Alzheimer's disease: a postmortem study. Nemeroff CB; Kizer JS; Reynolds GP; Bissette G Regul Pept; 1989 Apr; 25(1):123-30. PubMed ID: 2566190 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptides in Alzheimer's Disease: An Update. Petrella C; Di Certo MG; Barbato C; Gabanella F; Ralli M; Greco A; Possenti R; Severini C Curr Alzheimer Res; 2019; 16(6):544-558. PubMed ID: 31456515 [TBL] [Abstract][Full Text] [Related]
12. Cortical and subcortical neuropeptides in Alzheimer's disease. Auchus AP; Green RC; Nemeroff CB Neurobiol Aging; 1994; 15(4):589-95. PubMed ID: 7969745 [TBL] [Abstract][Full Text] [Related]
13. [Studies of cerebrospinal fluid diagnosis in Alzheimer's disease: a review of the literature and of current developments]. van Gool WA; Bolhuis PA Tijdschr Gerontol Geriatr; 1992 Dec; 23(6):212-6. PubMed ID: 1362298 [TBL] [Abstract][Full Text] [Related]
14. The neurochemistry of Alzheimer's disease. Engelborghs S; De Deyn PP Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374 [TBL] [Abstract][Full Text] [Related]
15. Neurotransmitters and neuropeptides in Alzheimer's disease. McDonald WM; Nemeroff CB Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509 [TBL] [Abstract][Full Text] [Related]
16. Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease. Lawlor BA; Ryan TM; Bierer LM; Schmeidler J; Haroutunian V; Mohs R; Davis KL Biol Psychiatry; 1995 Jun; 37(12):895-6. PubMed ID: 7548465 [No Abstract] [Full Text] [Related]
17. Involvement of neuropeptide systems in schizophrenia: human studies. Cáceda R; Kinkead B; Nemeroff CB Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866 [TBL] [Abstract][Full Text] [Related]
18. Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review. Strac DS; Muck-Seler D; Pivac N Psychiatr Danub; 2015 Mar; 27(1):14-24. PubMed ID: 25751428 [TBL] [Abstract][Full Text] [Related]
19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
20. Neuropeptidergic systems in plaques of Alzheimer's disease. Struble RG; Powers RE; Casanova MF; Kitt CA; Brown EC; Price DL J Neuropathol Exp Neurol; 1987 Sep; 46(5):567-84. PubMed ID: 2442313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]